SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000947871-14-000619
Filing Date
2014-09-19
Accepted
2014-09-19 17:26:35
Documents
3
Group Members
ORBIMED CAPITAL GP III LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss402650_sc13d.htm SC 13D 181688
2 JOINT FILING AGREEMENT ss402650_ex9901.htm EX-99.1 16504
3 CARVE OUT AGREEMENT ss402650_ex9904.htm EX-99.4 105049
  Complete submission text file 0000947871-14-000619.txt   304880
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address IM NEUENHEIMER FELD 582, 69120 HEIDELBERG 2M 000000
Business Address IM NEUENHEIMER FELD 582, 69120 HEIDELBERG 2M 000000 49-6221-65307
Affimed N.V. (Subject) CIK: 0001608390 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88320 | Film No.: 141112709
SIC: 2834 Pharmaceutical Preparations